Work

Efficacy and Safety of Deferasirox (Exjade®) with up to 4.5 Years of Treatment in Patients with Thalassemia Major: A Pooled Analysis

Year: 2008

Type: article

Source: Blood

DOI: 10.1182/blood.v112.11.5411.5411

Authors: Maria Domenica Cappellini, Renzo Galanello, Antonio Piga, Alan Cohen, Antonis Kattamis, Yesim Aydinok, Paul Williamson, Lisa Rojkjaer, John B Porter

Institutions: University of Milan, University of Cagliari, University of Turin, Children's Hospital of Philadelphia, National and Kapodistrian University of Athens, Ege University, Novartis (United States), Novartis (Switzerland), University College London

Language: English

Topic: Hemoglobinopathies and Related Disorders

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2553099295

FWCI: 1.377

Cites:

Cited by: 12

Related to: 10